GLP-1 receptor agonist
GLP-1 receptor agonists are a group of medications used in the treatment of type 2 diabetes and obesity. They work by mimicking the functions of the natural glucagon-like peptide-1 (GLP-1) in the body, which is involved in glucose metabolism and appetite regulation.
Mechanism of Action[edit | edit source]
GLP-1 receptor agonists work by binding to the GLP-1 receptor, which is found on the surface of certain cells in the pancreas. This binding stimulates the release of insulin, a hormone that helps regulate blood sugar levels. In addition, GLP-1 receptor agonists slow down the rate at which the stomach empties, which can help control appetite and lead to weight loss.
Uses[edit | edit source]
GLP-1 receptor agonists are primarily used in the treatment of type 2 diabetes. They can be used alone or in combination with other diabetes medications. Some GLP-1 receptor agonists are also approved for the treatment of obesity.
Side Effects[edit | edit source]
Common side effects of GLP-1 receptor agonists include nausea, vomiting, diarrhea, and constipation. In rare cases, they can cause pancreatitis, a serious inflammation of the pancreas.
Examples[edit | edit source]
Examples of GLP-1 receptor agonists include exenatide (Byetta), liraglutide (Victoza), dulaglutide (Trulicity), and semaglutide (Ozempic).
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD